182 related articles for article (PubMed ID: 20809682)
1. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study.
Renard E; Guerci B; Leguerrier AM; Boizel R;
Diabetes Technol Ther; 2010 Oct; 12(10):769-73. PubMed ID: 20809682
[TBL] [Abstract][Full Text] [Related]
2. Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies.
Gibney M; Xue Z; Swinney M; Bialonczyk D; Hirsch L
Diabetes Technol Ther; 2016 Mar; 18(3):136-43. PubMed ID: 26701357
[TBL] [Abstract][Full Text] [Related]
3. Needle detachment from the Sure-T infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia.
Massa G; Gys I; Eyndt AO; Wauben K; Vanoppen A
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):237-9. PubMed ID: 25153227
[TBL] [Abstract][Full Text] [Related]
4. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
5. Unexplained hyperglycemia in continuous subcutaneous insulin infusion: evaluation and treatment.
Ponder SW; Skyler JS; Kruger DF; Matheson D; Brown BW
Diabetes Educ; 2008; 34(2):327-33. PubMed ID: 18375782
[TBL] [Abstract][Full Text] [Related]
6. Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes.
Binder E; Lange O; Edlinger M; Meraner D; Abt D; Moser C; Steichen E; Hofer SE
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):260-4. PubMed ID: 25607337
[TBL] [Abstract][Full Text] [Related]
7. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G
Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
[TBL] [Abstract][Full Text] [Related]
8. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.
Hoogma RP; Schumicki D
Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727
[TBL] [Abstract][Full Text] [Related]
9. Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3.
Schmid V; Hohberg C; Borchert M; Forst T; Pfützner A
J Diabetes Sci Technol; 2010 Jul; 4(4):976-82. PubMed ID: 20663464
[TBL] [Abstract][Full Text] [Related]
10. Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life.
Freckmann G; Arndt S; Fießelmann A; Klausmann G; Pralle K; Künsting T; Petersen B
J Diabetes Sci Technol; 2017 Mar; 11(2):253-259. PubMed ID: 27605591
[TBL] [Abstract][Full Text] [Related]
11. Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control.
Radermecker RP; Renard E; Scheen AJ
Diabetes Metab Res Rev; 2009 Sep; 25(6):491-501. PubMed ID: 19496088
[TBL] [Abstract][Full Text] [Related]
12. Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans.
Clausen TS; Kaastrup P; Stallknecht B
Diabetes Technol Ther; 2009 Sep; 11(9):575-80. PubMed ID: 19764836
[TBL] [Abstract][Full Text] [Related]
13. Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study.
Pfützner A; Sachsenheimer D; Grenningloh M; Heschel M; Walther-Johannesen L; Gharabli R; Klonoff D
J Diabetes Sci Technol; 2015 Sep; 9(6):1292-8. PubMed ID: 26341262
[TBL] [Abstract][Full Text] [Related]
14. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
Pfützner A; Berger S; Spinas G
Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
[TBL] [Abstract][Full Text] [Related]
15. Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials.
Renard E; Baldet P; Picot MC; Jacques-Apostol D; Lauton D; Costalat G; Bringer J; Jaffiol C
Diabetes Care; 1995 Mar; 18(3):300-6. PubMed ID: 7555471
[TBL] [Abstract][Full Text] [Related]
16. Stabilized human insulin prevents catheter occlusion during continuous subcutaneous insulin infusion.
Walter HM; Timmler R; Mehnert H
Diabetes Res; 1990 Feb; 13(2):75-7. PubMed ID: 2091873
[TBL] [Abstract][Full Text] [Related]
17. Tissue Response to Subcutaneous Infusion Catheter.
Zhang E; Cao Z
J Diabetes Sci Technol; 2020 Mar; 14(2):226-232. PubMed ID: 30931603
[TBL] [Abstract][Full Text] [Related]
18. [Benefits of subcutaneous continuous insulin infusion in type 1 diabetic patients with high glycemic variability].
Prieto-Tenreiro A; Villar-Taibo R; Pazos-Couselo M; González-Rodríguez M; Casanueva F; García-López JM
Endocrinol Nutr; 2012 Apr; 59(4):246-53. PubMed ID: 22440045
[TBL] [Abstract][Full Text] [Related]
19. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
[TBL] [Abstract][Full Text] [Related]
20. Duration of Catheter Use in Patients with Diabetes Using Continuous Subcutaneous Insulin Infusion: A Review.
Bonato L; Taleb N; Gingras V; Messier V; Gobeil F; Ménard J; Ardilouze JL; Rabasa-Lhoret R
Diabetes Technol Ther; 2018 Jul; 20(7):506-515. PubMed ID: 29958025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
